SEC Form 4 · accession 0001178913-17-002876
Artemis Therapeutics, Inc. · ATMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian M Culley
Officer — Chief Executive Officer
Period of report
Oct 23, 2017
Accepted (ET)
Oct 25, 2017 · 8:12 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 23, 2017 | P$0 | 25,000 | — | A | 25,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF1 | $2.00 | Oct 23, 2017 | P | 12,500 | A | Oct 23, 2017 | Oct 23, 2022 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The reported securities consist of units purchased by the reporting person for $1.00 per unit.